Jaslok hospital advises doctors against prescribing Ranbaxy drugs

Health Care Comments Off

Jaslok Mumbai hospital has put up a notice advising its doctors to avoid prescribing drugs manufactured by Ranbaxy Laboratories. This comes a fortnight after Ranbaxy Laboratories agreed to pay a $500-million penalty to US authorities for “selling adulterated drugs” in the American market. It is not known whether the two are linked, reports TOI.
In 2008-09, the US Food and Drug Administration found the company had not followed adequate rules in manufacturing drugs meant for the American market. This resulted in a ban of around 30 Ranbaxy drugs.